Phase 3 Resectable Lung Non-Small Cell Carcinoma Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Resectable Lung Non-Small Cell Carcinoma+1 more

Alliance for Clinical Trials in Oncology1,100 enrolled378 locationsNCT06632327

Recruiting

Phase 3

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Carcinoma, Non-Small Cell LungResectable Lung Non-Small Cell CarcinomaLung Diseases

Fundación GECP129 enrolled32 locationsNCT06431633